Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-137544

Chief Legal Officer acquired 165,938 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-13 Grant or award : show line 1 in the form +165,938 385,294 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-12-13 Grant or award : show line 2 in the form Stock Option +331,875 331,875 D
2024-12-13 Grant or award : show line 3 in the form Stock Option +325,000 325,000 D
Loading xslF345X05/ownership.xml…